All Phenotypes Mapkapk5<tm1Pqs> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Mapkapk5^tm1Pqs/Mapkapk5^tm1Pqs	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:3723513
ht2	Mapkapk5^tm1Pqs/Mapkapk5⁺	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:3723514
cx3	Mapkapk5^tm1Pqs/Mapkapk5^tm1Pqs Tg(SV40-NRAS*G12D)1Sco/?	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:3757991
cx4	Mapkapk5^tm1Pqs/Mapkapk5⁺ Tg(SV40-NRAS*G12D)1Sco/?	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:3757992

Allelic Composition	Mapkapk5^tm1Pqs/Mapkapk5^tm1Pqs
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapkapk5^tm1Pqs mutation (0 available); any Mapkapk5 mutation (30 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:117893 )

• 1 of 13 mice died of unidentifiable causes following treatment with DMBA

neoplasm

increased skin papilloma incidence ( J:117893 )

• 7 of 13 mice developed skin papillomas following treatment with DMBA compared to only 1 of 12 wild-type mice

• however, mice do not show altered susceptibility in terms of incidence or latency to skin cancer following TPA and DMBA treatment

• DMBA-induced tumors grow slowly but progressively and usually reach a size of more than 10 mm in diameter within 2-3 weeks after initial detection compared to tumors in wild-type mice that seem to be dormant and remain at about 2 to 3 mm in diameter after 2 months from initial detection

• DMBA-induced tumors also had more complicated structures with much thinner and more folded layers of squamous epithelium

• DMBA-induced tumors express less senescence markers than wild-type DMBA-induced tumors

• however, untreated mice are healthy and tumor-free for at least 2 years

cellular

delayed cellular replicative senescence ( J:117893 )

• mouse skin fibroblast cells derived from mice express less ras-induced senescence markers than wild-type DMBA-induced tumors

integument

increased skin papilloma incidence ( J:117893 )

• 7 of 13 mice developed skin papillomas following treatment with DMBA compared to only 1 of 12 wild-type mice

• however, mice do not show altered susceptibility in terms of incidence or latency to skin cancer following TPA and DMBA treatment

• DMBA-induced tumors also had more complicated structures with much thinner and more folded layers of squamous epithelium

• DMBA-induced tumors express less senescence markers than wild-type DMBA-induced tumors

• however, untreated mice are healthy and tumor-free for at least 2 years

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased skin papilloma incidence ( J:117893 )

• 12 of 30 mice developed skin papillomas following treatment with DMBA compared to only 1 of 12 wild-type mice and 7 of 13 in Mapkapk5^tm1Pqs homozygotes

• however, mice do not show altered susceptibility in terms of incidence or latency to skin cancer following TPA and DMBA treatment

• only one papilloma progressed to malignant carcinoma 5 months after detection

• DMBA-induced tumors grow slowly but progressively and usually reach a size of more than 10mm in diameter within 2-3 weeks after initial detection compared to tumors in wild-type mice that seem to be dormant and remain at about 2 to 3 mm in diameter after 2 months from initial detection

• DMBA-induced tumors also had more complicated structures with much thinner and more folded layers of squamous epithelium

• DMBA-induced tumors express less senescence markers than wild-type DMBA-induced tumors

• however, untreated mice are healthy and tumor-free for at least 2 years

cellular

delayed cellular replicative senescence ( J:117893 )

• mouse skin fibroblast cells derived from mice express less ras-induced senescence markers than wild-type DMBA-induced tumors

integument

increased skin papilloma incidence ( J:117893 )

• 12 of 30 mice developed skin papillomas following treatment with DMBA compared to only 1 of 12 wild-type mice and 7 of 13 in Mapkapk5^tm1Pqs homozygotes

• however, mice do not show altered susceptibility in terms of incidence or latency to skin cancer following TPA and DMBA treatment

• only one papilloma progressed to malignant carcinoma 5 months after detection

• DMBA-induced tumors grow slowly but progressively and usually reach a size of more than 10mm in diameter within 2-3 weeks after initial detection compared to tumors in wild-type mice that seem to be dormant and remain at about 2 to 3 mm in diameter after 2 months from initial detection

• DMBA-induced tumors also had more complicated structures with much thinner and more folded layers of squamous epithelium

• DMBA-induced tumors express less senescence markers than wild-type DMBA-induced tumors

• however, untreated mice are healthy and tumor-free for at least 2 years

Allelic Composition	Mapkapk5^tm1Pqs/Mapkapk5^tm1Pqs Tg(SV40-NRAS*G12D)1Sco/?
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapkapk5^tm1Pqs mutation (0 available); any Mapkapk5 mutation (30 available)
Tg(SV40-NRAS*G12D)1Sco mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased lymphoma incidence ( J:117893 )

• lymphomagenesis is enhanced in the few surviving mice relative to in Tg(SV40-NRAS*G12D)1Sco mice

Allelic Composition	Mapkapk5^tm1Pqs/Mapkapk5⁺ Tg(SV40-NRAS*G12D)1Sco/?
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapkapk5^tm1Pqs mutation (0 available); any Mapkapk5 mutation (30 available)
Tg(SV40-NRAS*G12D)1Sco mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased lymphoma incidence ( J:117893 )

• lymphomagenesis is enhanced relative to in Tg(SV40-NRAS*G12D)1Sco mice

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24